NEU neuren pharmaceuticals limited

Wait what? The way I read this, is that the FDA can issue...

  1. 102 Posts.
    lightbulb Created with Sketch. 6
    Wait what? The way I read this, is that the FDA can issue another Voucher?

    Trofinetide has been granted Fast Track Status and Orphan Drug Designation for the treatment of Rett syndrome in the United States. An NDA with Orphan Drug Designation is eligible for priority review. Trofinetide has also been granted Rare Pediatric Disease (RPD) designation by the FDA. With such designation, Acadia expects to be awarded a Priority Review Voucher if the NDA is approved.

    Why would they type "to be awareded a Priority Review Voucher"? I thought they already have one for Trofinetide?
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$13.88
Change
-0.140(1.00%)
Mkt cap ! $1.727B
Open High Low Value Volume
$13.90 $14.21 $13.64 $4.590M 329.8K

Buyers (Bids)

No. Vol. Price($)
1 600 $13.85
 

Sellers (Offers)

Price($) Vol. No.
$13.96 2894 1
View Market Depth
Last trade - 16.10pm 08/07/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.